Research-Related Updates Regarding COVID-19

MU officials continue to closely monitor the outbreak of the respiratory illness. The university remains open; however, supervisors and employees are strongly encouraged to work remotely. Please refer to MU Alert for the latest updates and information.

As the local community cautiously moves out of the stay-at-home phase of the current pandemic, MU is pursuing the first steps of a phased approach for returning to campus. Please refer to the Office of Research and Economic Development’s research and creative works restart page for information and guidelines.

The Office of Research and Economic Development has created a page for Research-Related Updates Regarding COVID-19 to provide information and guidance for our research community to facilitate research continuity during the coronavirus outbreak.

Research News


Photo of cells found in lung cancer patients may predict survival.Unique cells found in lung cancer patients may predict survival

Lung cancer is the leading cause of cancer-related deaths in the U.S. and most who are diagnosed with lung cancer do not survive five years. Non-small cell lung cancer (NSCLC) is the most common type where tumor cells shed from the main tumor circulate in the blood and settle in other organs and metastasize.

   In some cases, surgery can remove the primary tumor, but investigators from the University of Missouri School of Medicine and MU Health Care have identified a type of cell fusion between cancer cells and white blood cells called a tumor-macrophage fusion (TMF) where the size and number of the TMF cells may predict survival.


Photo - Chen brings precision health research expertise to Department of Surgery Chen brings precision health research expertise to Department of Surgery

Shiyou Chen, DVM, PhD, joined the MU School of Medicine in September 2019 as the chief of the Department of Surgery’s new division of research. His job is to foster collaborations between MU’s surgeons and basic scientists, which aligns perfectly with the university system’s NextGen Precision Health Initiative.

   Chen, who spent the previous 11 years at the University of Georgia’s College of Veterinary Medicine, brought four active National Institutes of Health R01 grants worth more than $5.8 million over five years to MU. Chen’s project closest to the finish line is a drug that could be used to coat the stents that reopen narrowed arteries.



ORED invests in our faculty’s success through ResearchFRST.  The program offers resources, support and training that enable professional development, large interdisciplinary project grant support and research incentive programs.

New> Research Development Programs
Early Career Research Development Fellows Program & Mid-Career Research Development Fellows Program

Read More